Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Immobilized Transaminase Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117467733B reveals immobilized transaminase process for Sitagliptin. Achieve high optical purity and cost reduction in API manufacturing with scalable biocatalysis.
Patent CN110129306A details immobilized transaminase for besifloxacin intermediates. Offers high purity, reusability, and scalable manufacturing solutions for global pharmaceutical supply chains.